RadNet [RDNT] vs Charles River [CRL] Detailed Stock Comparison

RadNet Inc.

NASDAQ
Loading...

Charles River Laboratories International, Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: RadNet Inc. wins in 6 metrics, Charles River Laboratories International, Inc. wins in 14 metrics, with 0 ties. Charles River Laboratories International, Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric RadNet Inc. Charles River Laboratories International, Inc. Better
P/E Ratio (TTM) 1,425.75 681.33 Charles River Laboratories International, Inc.
Price-to-Book Ratio 4.01 2.61 Charles River Laboratories International, Inc.
Debt-to-Equity Ratio 137.10 81.95 Charles River Laboratories International, Inc.
PEG Ratio 54.97 20.54 Charles River Laboratories International, Inc.
EV/EBITDA 23.62 12.23 Charles River Laboratories International, Inc.
Profit Margin (TTM) -0.91% -3.60% RadNet Inc.
Operating Margin (TTM) 6.83% 4.51% RadNet Inc.
EBITDA Margin (TTM) 6.83% 4.51% RadNet Inc.
Return on Equity 1.37% -4.23% RadNet Inc.
Return on Assets (TTM) 1.61% 4.24% Charles River Laboratories International, Inc.
Free Cash Flow (TTM) $85.57M $518.49M Charles River Laboratories International, Inc.
1-Year Return -3.41% 33.24% Charles River Laboratories International, Inc.
Price-to-Sales Ratio (TTM) 2.17 2.06 Charles River Laboratories International, Inc.
Enterprise Value $5.74B $10.72B Charles River Laboratories International, Inc.
EV/Revenue Ratio 2.81 2.67 Charles River Laboratories International, Inc.
Gross Profit Margin (TTM) 13.86% 31.15% Charles River Laboratories International, Inc.
Revenue per Share (TTM) $27 $81 Charles River Laboratories International, Inc.
Earnings per Share (Diluted) $-0.25 $-2.90 RadNet Inc.
Beta (Stock Volatility) 1.53 1.62 RadNet Inc.
Short % of Float 13.15% 10.71% Charles River Laboratories International, Inc.

RadNet Inc. vs Charles River Laboratories International, Inc. Stock Performance Analysis

Loading Price Chart...

RDNT
CRL

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
RadNet Inc.-4.49%0.35%-6.78%-27.80%-31.08%-23.45%
Charles River Laboratories International, Inc.2.91%11.47%1.39%-2.18%-0.03%-13.69%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
RadNet Inc.-3.41%82.78%107.98%955.70%1,150.68%1,855.28%
Charles River Laboratories International, Inc.33.24%-9.95%-46.35%110.50%383.44%347.52%

Performance & Financial Health Analysis: RadNet Inc. vs Charles River Laboratories International, Inc.

MetricRDNTCRL
Market Information
Market Cap i$4.51B$8.28B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i789,143761,885
90 Day Avg. Volume i835,088865,618
Last Close$51.87$179.87
52 Week Range$50.76 - $85.84$132.65 - $228.88
% from 52W High-39.57%-21.41%
All-Time High$93.65 (Nov 11, 2024)$460.21 (Sep 20, 2021)
% from All-Time High-44.61%-60.92%
Growth Metrics
Quarterly Revenue Growth0.15%-0.01%
Quarterly Earnings GrowthN/A-0.01%
Financial Health
Profit Margin (TTM) i-0.01%-0.04%
Operating Margin (TTM) i0.07%0.05%
Return on Equity (TTM) i0.01%-0.04%
Debt to Equity (MRQ) i137.1081.95
Cash & Liquidity
Book Value per Share (MRQ)$14.08$64.30
Cash per Share (MRQ)$9.89$4.34
Operating Cash Flow (TTM) i$298.82M$737.65M
Levered Free Cash Flow (TTM) i$180.29M$572.38M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/A$0.00

Valuation & Enterprise Metrics Analysis: RadNet Inc. vs Charles River Laboratories International, Inc.

MetricRDNT (Apr 26, 2026)CRL (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i1,425.75681.33
Forward P/E i54.9713.59
PEG Ratio i54.9720.54
Price to Sales (TTM) i2.172.06
Price to Book (MRQ) i4.012.61
Market Capitalization
Market Capitalization i$4.51B$8.28B
Enterprise Value i$5.74B$10.72B
Enterprise Value Metrics
Enterprise to Revenue i2.812.67
Enterprise to EBITDA i23.6212.23
Risk & Other Metrics
Beta i1.531.62
Book Value per Share (MRQ) i$14.08$64.30

Financial Statements Comparison: RadNet Inc. vs Charles River Laboratories International, Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricRDNT (2025)CRL (2025)
Revenue/Sales i2.04B4.02B
Cost of Goods Sold i1.80B2.69B
COGS % of Revenue i88.5%67.0%
Gross Profit i235.49M1.32B
Gross Margin i11.5%33.0%
Research & Development iN/AN/A
Operating Income (EBIT) i83.36M401.14M
Operating Margin i4.1%10.0%
EBITDA i342.29M786.81M
EBITDA Margin i16.8%19.6%
Pre-Tax Income i31.91M-99.50M
Pre-Tax Income % of Revenue i1.6%-2.5%
Income Tax i14.86M42.66M
Income Tax % of Revenue i0.7%1.1%
Net Income (Profit) i17.05M-142.16M
Profit Margin i0.8%-3.5%

Balance Sheet & Liquidity Metrics

MetricRDNT (2025)CRL (2025)
Cash & Equivalents i767.22M213.77M
Total Current Assets i1.03B1.45B
Total Current Assets % of Revenue i50.6%36.0%
Total Current Liabilities i586.76M1.12B
Total Current Liabilities % of Revenue i28.8%27.9%
Long-Term Debt i1.77B2.57B
Long-Term Debt % of Revenue i86.8%64.0%
Total Shareholders Equity i1.36B3.21B
Retained Earnings i-95.44M1.39B
Retained Earnings % of Revenue i-4.7%34.6%
Property, Plant & Equipment i1.57B361.42M

Cash Flow Statement Comparison

MetricRDNT (2025)CRL (2025)
Operating Cash Flow i285.58M194.22M
Operating Cash Flow % of Revenue i14.0%4.8%
Capital Expenditures i-211.96MN/A
Free Cash Flow i85.57M518.49M
FCF Margin i4.2%12.9%
Debt Repayment i-27.78M-1.35B
Common Stock Repurchase iN/A-360.67M

Short Interest & Institutional Ownership Analysis

MetricRDNTCRL
Shares Short i8.66M4.59M
Short Ratio i9.695.18
Short % of Float i13.15%10.71%
Shares Outstanding i77.40M49.22M
Float Shares i65.66M48.66M
% Held by Insiders i10.02%0.85%
% Held by Institutions i99.10%110.31%
% Held by Public i-9.12%-11.16%

Dividend Analysis & Yield Comparison: RadNet Inc. vs Charles River Laboratories International, Inc.

MetricRDNTCRL
Last 12-Month Dividend iN/A$0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/A$0.00
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/A$0.00
Ex-Dividend DateN/AN/A